HEMISPHERX BIOPHARMA INC Uncategorized Contracts & Agreements

65 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Japanese National Institute of Infectious Disease
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Unrestricted Grant Agreement between AIM ImmunoTech Inc. and Erasmus University Medical Center Rotterdam (Pulmonary Medicine)
Funding Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Supplementary Agreement II to Material Transfer and Research Agreement between AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Supplementary Agreement II to Material Transfer and Research Agreement between AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Supplementary Agreement to Material Transfer and Research Agreement between AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Amendment 1 to Project AIM02 Statement of Work and Budget between AIM ImmunoTech Inc. and Amarex Clinical Research, LLC
Development Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Warrant Repricing and Exercise Agreement between Company and Sabby Healthcare Master Fund, Ltd. & Sabby Volatility Warrant Master Fund, Ltd.
Warrant Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2019
Form of Dealer - Manager Agreement
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2019
Bill of Sale between Hemispherx Biopharma, Inc. and 783 Jersey Avenue LLC (Amended, March 16, 2018)
Purchase Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Amendment No. 4 to Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Amendment No. 3 to Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
First Amendment to Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Modification Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2018
Warrant Repricing and Issuance Agreement between Hemispherx Biopharma, Inc. and Warrant Holder (May 31, 2017)
Warrant Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
Promissory Note between Hemispherx Biopharma, Inc. and SW Partners LLC dated May 12, 2017
Note Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NJ
2017
Securities Purchase Agreement between Hemispherx BioPharma, Inc. and Purchasers (February 1, 2017)
Purchase Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2017
Amended and Restated Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
Securities Purchase Agreement between Hemispherx BioPharma, Inc. and Purchasers (August 30, 2016)
Purchase Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2016
Lock-Up Agreement between AIM ImmunoTech Inc. and Securityholder for Registered Securities Offering
HEMISPHERX BIOPHARMA INC
Biotechnology
2025
Amended and Restated Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and Roswell Park Cancer Institute Corporation
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Consulting Agreement Term Extension between AIM ImmunoTech Inc. and Foresite Advisors, LLC
Consulting Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Co-ordination Agreement among Erasmus University Medical Center, AIM ImmunoTech Inc., and AstraZeneca BV for DURIPANC Study
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Investigator Initiated Study Support Agreement between Erasmus University Medical Center Rotterdam and AIM ImmunoTech Inc.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Material Transfer Agreement between AIM ImmunoTech Inc. and University of Pittsburgh – Of the Commonwealth System of Higher Education
Supply Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and University of Pittsburgh
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Project Work Order Proposal between Amarex Clinical Research, LLC and AIM ImmunoTech Inc. for Phase II Ampligen Trial Services
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Project Work Order Proposal between Amarex Clinical Research, LLC and AIM ImmunoTech Inc. for Phase II Pancreatic Cancer Study
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and University of Cagliari
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Roswell Park Cancer Institute
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2021
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Leyden Laboratories B.V.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
Clinical Trial Services Agreement between AIM ImmunoTech Inc. and Centre for Human Drug Research (CHDR)
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2021
Project Work Order Proposal between AIM ImmunoTech, Inc. and Amarex Clinical Research, LLC for Phase I/II Ampligen Clinical Trial
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2020
Clinical Trial Agreement between Roswell Park Cancer Institute and AIM ImmunoTech Inc. for Phase 1b Rintatolimod/IFNα Study
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech Inc., Japanese National Institute of Infectious Disease, and Shionogi & Co., Ltd.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and University of Rochester
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and Shenzhen Smoore Technology Limited
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Amendment No. 1 to Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Roswell Park Cancer Institute Corporation
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Clinical Trial Agreement between Roswell Park Cancer Institute Corporation and Hemispherx Biopharma, Inc.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2018
Amendment No. 2 to Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Financial Advisory and Placement Agent Agreement between Hemispherx Biopharma, Inc. and Ascendiant Capital Markets, LLC
Advisory Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Amended and Restated Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2017